| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d93b275c128310c6df8116a0d76c32cd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2007-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853bd6f2cf13aac334b2f8e16d4a8d5d |
| publicationDate |
2009-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2023142-A1 |
| titleOfInvention |
Immunoassay utilizing recombinant nucleocapsid-proteins for detection of antibodies to human coronaviruses |
| abstract |
A test kit for the immunological diagnosis of a SARS virus infection in a sample is disclosed which comprises at least a fragment of the nucleocapsid protein N of a SARS virus and at least one fragment of a nucleocapsid protein N of another coronavirus selected from the group comprising the coronaviruses NL63, 229E, HKU1 and OC43. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102020117636-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015057666-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114277184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114277184-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022141776-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022003180-A1 |
| priorityDate |
2007-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |